Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Five Healthcare Predictions from Sam Glick and Terry Stone

2020 was a transformative year. Here's what might happen next with COVID-19, pharmacy cost, telehealth, and more.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

With bid season approaching, payers' pharmacy teams must re-evaluate how to competitively position themselves for success.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

A digital tool to humanize care is helping clinicians use empathy to transform care delivery.

CEO, PatientWisdom/NRC Health

Future Truths: Inevitable and Inspiring

Through the remarkable response to world-changing events, leaders have proven they're truly able to get further, faster.

Featured in the Middle East Insurance Review

COVID-19 sparked health system disruption in the Middle East. Here are some emerging digital health trends and mid-term insurer implications.

Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Future Truths: Inevitable and Inspiring

Harnessing genomics will transform our daily lives, disrupt payer, provider, and pharma business models, and create new markets for next-generation prevention.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman

How to leverage voice-enabled digital physician assistants to address clinical documentation burden and physician burnout.

Founder and CEO, Suki
Partner, Health & Life Sciences, Oliver Wyman

To transform healthcare, our data must be more representative of the people we serve and the problems they face.

Timeline to Normalcy - Updated January 25, 2021

The journey to normalcy involves understanding and addressing many different factors. Our latest analysis suggests we are likely to achieve pHIT in the US on average in late summer.

Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Why closing the loop and creating a virtuous health promotion cycle will transform "sick care" to "well-care."

Partner, Health and Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Insights in your inbox

Subscribe